NVS
Novartis AG
Stock
$141.00−0.05 (−0.04%)Close Oct 2, 2026
- Research and development, 2025
- $11.2B
- YoY, 2025
- +11.8%
- 5-year CAGR
- +4.5%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $11.2B | +11.8% |
| 2024 | $10.0B | −11.9% |
| 2023 | $11.4B | +24.0% |
| 2022 | $9.2B | +6.1% |
| 2021 | $8.6B | −3.8% |
| 2020 | $9.0B | −4.5% |
| 2019 | $9.4B | +10.8% |
| 2018 | $8.5B | +1.2% |
| 2017 | $8.4B | −7.2% |
| 2016 | $9.0B | — |